Testosterone Cypionate/Propionate Injection Recalled for Sterility Assurance
New Vitalis Pharmacy is recalling Testosterone Cypionate and Testosterone Propionate injections nationwide due to lack of assurance of sterility. The recall affects 1,347 vials distributed across multiple lots.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA has classified this as a Class II recall. Lack of sterility assurance in injectable medications poses a significant risk of serious infection and potential hospitalization. Class II recalls with injectable products involving sterility failures meet the threshold for Severe.
Plain-English summary
New Vitalis Pharmacy LLC is recalling Testosterone Cypionate/Testosterone Propionate (180mg/mL and 20mg/mL) injectable medication in 1 mL vials due to lack of assurance of sterility. The recalled product was distributed nationwide in the United States.
The recall involves six lots with expiration dates ranging from September 18, 2021 to October 23, 2021: Lot #AL07202021@901 (Exp 9/18/21), Lot #AL07272021@901 (Exp 9/25/21), Lot #AL08032021@901 (Exp 10/2/21), Lot #AL08102021@901 (Exp 10/9/21), Lot #AL08172021@901 (Exp 10/16/21), and Lot #AL08242021@901 (Exp 10/23/21). A total of 1,347 vials are affected.
Patients currently using this product should contact their healthcare provider or pharmacy immediately. Do not use any vials from the recalled lots. Consult with your healthcare provider about appropriate next steps and possible replacement therapy.
The recalled product
- Product
- Testosterone Cypionate Testosterone Propionate, 180mg/mL, 20mg/mL, 1 mL vial, Rx only, New Vitalis Pharmacy 4139 Cadillac Ct # 201 Louisville, KY 40213
- Manufacturer
- New Vitalis Pharmacy LLC dba New Vitalis Pharmacy
- Category
- Drug — Injectable Hormone
- Hazard
- sterility-assurance
- contamination-risk
- injection-infection
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (13)
- Lot
- expiry: Lot #AL07202021@901
- Exp 9/18/21
- Lot #AL07272021@901
- Exp 9/25/21
- Lot #AL08032021@901
- Exp 10/2/21
- Lot #AL08102021@901
- Exp 10/9/21
- Lot #AL08172021@901
- Exp 10/16/21
- Lot #AL08242021@901
- Exp 10/23/21
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27